Which of the following anticancer drug causes hemolyticuremic syndrome:: (A) Vincristine, (B) Vinblastine, (C) Cisplatin, (D) Mitomycin
Answer is D. Ans. (d) MitomycinRef.: KDT 6th ed. / 827* After 8-10 months of start of mitomycin-C treatment, the drug leads to endothelial damage* The Renal lesions seen are similar to those seen in idiopathic HUS and include arteriolar fibrin thrombi, expanded sub-endothelial zones in glomerular capillary walls.